Molecular prognostic factors and outcome among a cohort of patients with monoclonal B-cell lymphocytosis (MBL)

被引：0
|
作者：
Maddocks-Christianson, Kami [1 ]
Hanson, Curtis A. [1 ]
Jenkins, Greg [1 ]
Zent, Clive S. [1 ]
Slager, Susan L. [1 ]
Call, Timothy G. [1 ]
Bowen, Deborah [1 ]
Tschumper, Renee [1 ]
Jelinek, Diane F. [1 ]
Kay, Neil E. [1 ]
Shanafelt, Tait D. [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
来源：
BLOOD | 2007年 / 110卷 / 11期
关键词：
D O I：
10.1182/blood.V110.11.748.748
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
748
引用
收藏
页码：230A / 230A
页数：1
相关论文
共 50 条
  • [31] Health impact of monoclonal gammopathy of undetermined significance (MGUS) and monoclonal B-cell lymphocytosis (MBL): findings from a UK population-based cohort
    Lamb, Maxine J. E.
    Smith, Alexandra
    Painter, Daniel
    Kane, Eleanor
    Bagguley, Timothy
    Newton, Robert
    Howell, Debra
    Cook, Gordon
    de Tute, Ruth
    Rawstron, Andrew
    Patmore, Russell
    Roman, Eve
    BMJ OPEN, 2021, 11 (02):
  • [32] Clonal evolution is a prognostic factor for the clinical progression of monoclonal B-cell lymphocytosis
    I V Kostopoulos
    G Paterakis
    D Pavlidis
    E Kastritis
    E Terpos
    O E Tsitsilonis
    S I Papadhimitriou
    Blood Cancer Journal, 2017, 7 : e597 - e597
  • [33] Genetic and clinical relation between monoclonal B-cell lymphocytosis (MBL) and chronic lymphocytic leukemia (CLL)
    Kern, W.
    Haferlach, C.
    Dicker, F.
    Schnittger, S.
    Haferlach, T.
    ONKOLOGIE, 2010, 33 : 20 - 21
  • [34] Monoclonal B-cell lymphocytosis (MBL) in CLL families: substantial increase in relative risk for young adults
    R de Tute
    M Yuille
    D Catovsky
    R S Houlston
    P Hillmen
    A C Rawstron
    Leukemia, 2006, 20 : 728 - 729
  • [35] Clonal evolution is a prognostic factor for the clinical progression of monoclonal B-cell lymphocytosis
    Kostopoulos, I. V.
    Paterakis, G.
    Pavlidis, D.
    Kastritis, E.
    Terpos, E.
    Tsitsilonis, O. E.
    Papadhimitriou, S. I.
    BLOOD CANCER JOURNAL, 2017, 7 : e597 - e597
  • [36] Monoclonal B-cell lymphocytosis in relatives of patients with chronic B-cell lymphoproliferative disorders in Colombia
    Celis, Mike
    Navarro, Yohanna
    Serrano, Norma
    Martinez, Daniel
    Nieto, Wendy
    BIOMEDICA, 2023, 43
  • [37] Monoclonal B-cell lymphocytosis (MBL) in CLL families: substantial increase in relative risk for young adults
    de Tute, R
    Yuille, M
    Catovsky, D
    Houlston, RS
    Hillmen, P
    Rawstron, AC
    LEUKEMIA, 2006, 20 (04) : 728 - 729
  • [38] B-CELL COUNT AND TIME TO FIRST TREAMENT: DIFFERENTIATING CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) FROM MONOCLONAL B-CELL LYMPHOCYTOSIS (MBL) BASED ON CLINICAL OUTCOME: THE GIMEMA EXPERIENCE
    Molica, S.
    Mauro, F.
    Callea, V.
    Giannarelli, D.
    Lauria, F.
    Cortelezzi, A.
    Liso, V.
    Foa, R.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 328 - 328
  • [39] Clinical Implications of Monoclonal B-Cell Lymphocytosis
    Parikh, Sameer A.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S92 - S93
  • [40] New Insights into Monoclonal B-Cell Lymphocytosis
    Kalpadakis, Christina
    Pangalis, Gerassimos A.
    Sachanas, Sotirios
    Vassilakopoulos, Theodoros P.
    Kyriakaki, Stavroula
    Korkolopoulou, Penelope
    Koulieris, Efstathios
    Moschogiannis, Maria
    Yiakoumis, Xanthi
    Tsirkinidis, Pantelis
    Kyrtsonis, Marie-Christine
    Levidou, Georgia
    Papadaki, Helen A.
    Panayiotidis, Panayiotis
    Angelopoulou, Maria K.
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
12345